المؤلفون: Bamias, A, Merseburger, A, Loriot, Y, James, N, Choy, E, Castellano, D, Lopez-Rios, F, Calabrò, F, Kramer, M, de Velasco, G, Zakopoulou, R, Tzannis, K, Sternberg, CN

المساهمون: James, Nicholas

مصطلحات موضوعية: Immunotherapy, Urinary Bladder Neoplasms, Humans, Prognosis, Carcinoma, Transitional Cell, Immune Checkpoint Inhibitors, Prospective Studies, Urologic Neoplasms, Hemoglobins

جغرافية الموضوع: England

وصف الملف: Print; application/pdf

العلاقة: ARTN e005977; jitc-2022-005977; Journal for ImmunoTherapy of Cancer, 2023, 11 (1), pp. e005977 -; https://repository.icr.ac.uk/handle/internal/6042Test

الإتاحة: https://doi.org/10.1136/jitc-2022-005977Test
https://repository.icr.ac.uk/handle/internal/6042Test

المؤلفون: Powles, T, Albiges, L, Bex, A, Comperat, E, Grünwald, V, Kanesvaran, R, Kitamura, H, McKay, R, Porta, C, Procopio, G, Schmidinger, M, Suarez, C, Teoh, J, de Velasco, G, Young, M, Gillessen, S

المصدر: Ann Oncol ; ISSN:1569-8041

مصطلحات موضوعية: ESMO Clinical Practice Guideline (CPG), ESMO-MCBS, diagnosis, management, renal cell carcinoma, treatment

العلاقة: https://doi.org/10.1016/j.annonc.2024.05.537Test; https://pubmed.ncbi.nlm.nih.gov/38788900Test

الإتاحة: https://doi.org/10.1016/j.annonc.2024.05.537Test
https://pubmed.ncbi.nlm.nih.gov/38788900Test

المؤلفون: Guerrero-Ramos, F., De Velasco, G., Duenas, M., Paramio, J., García, V.M., Gómez-Canizo, C., Rodríguez-Izquierdo, M., Hernández-Arroyo, M., Martín-Torres, M.P., Álvarez-Rodríguez, P., Suárez, C., Morales, L., Ponce, S., Rodríguez-Antolín, A., Castellano, D.

المصدر: European Urology ; volume 85, page S1701 ; ISSN 0302-2838

مصطلحات موضوعية: Urology

الإتاحة: https://doi.org/10.1016/s0302-2838Test(24)01302-2
https://api.elsevier.com/content/article/PII:S0302283824013022?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0302283824013022?httpAccept=text/plainTest

المؤلفون: Necchi, A., Hussain, S.A., Loriot, Y., de Velasco, G.

المصدر: European Urology ; volume 85, page S427 ; ISSN 0302-2838

مصطلحات موضوعية: Urology

الإتاحة: https://doi.org/10.1016/s0302-2838Test(24)00385-3
https://api.elsevier.com/content/article/PII:S0302283824003853?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0302283824003853?httpAccept=text/plainTest

المؤلفون: Grande, E, Alonso-Gordoa, T, Reig, O, Esteban, E, Castellano, D, Garcia-Del-Muro, X, Mendez, M J, García-Donas, J, González Rodríguez, M, Arranz-Arija, J A, Lopez-Criado, P, Molina-Cerrillo, J, Mellado, B, Alvarez-Fernandez, C, De Velasco, G, Cuéllar-Rivas, M A, Rodríguez-Alonso, R M, Rodríguez-Moreno, J F, Suarez-Rodriguez, C

مصطلحات موضوعية: immune checkpoint inhibitors, metastatic renal carcinoma, second-line treatment, sunitinib, Carcinoma, Renal Cell, Female, Humans, Indoles, Kidney Neoplasms, Male, Prospective Studies

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/22214Test; PMC9058923; http://www.esmoopen.com/article/S2059702922000813/pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058923/pdfTest

الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100463Test
http://hdl.handle.net/10668/22214Test
http://www.esmoopen.com/article/S2059702922000813/pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058923/pdfTest

المؤلفون: Pérez-Valderrama, Begoña, Suárez Rodríguez, Cristina, de‑Velasco, G., Beato, C., Chirivella, I., Lázaro, Martín

المساهمون: Institut Català de la Salut, Lázaro M Medical Oncology Department, Complexo Hospitalario Universitario de Vigo, Estrada Clara Campoamor 341, 36213 Vigo, Pontevedra, Spain. Valderrama BP Medical Oncology Department, Hospital Universitario Virgen del Rocío, Seville, Spain. Suárez C Servei de Medicina Oncològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. de-Velasco G Medical Oncology Department, Hospital Universitario, 12 de Octubre, Madrid, Spain. Beato C Medical Oncology Department, Hospital Universitario Virgen de la Macarena, Seville, Spain. Chirivella I Medical Oncology Department, Hospital Clínico, Universidad de Valencia, Valencia, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Ronyons - Càncer - Tractament, Protocols clínics, DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Kidney Neoplasms, Other subheadings::Other subheadings::/therapy, HEALTH SURVEILLANCE::Health Surveillance of Health Services::Delivery of Health Care::Patient Care::Therapeutics::Practice Guidelines as Topic, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias urológicas::neoplasias renales, Otros calificadores::Otros calificadores::/terapia, VIGILANCIA SANITARIA::vigilancia sanitaria de los servicios de salud::prestación sanitaria::asistencia al paciente::terapéutica::guías de práctica clínica como asunto

وصف الملف: application/pdf

العلاقة: Clinical and Translational Oncology;22; https://doi.org/10.1007/s12094-019-02285-7Test; Lázaro M, Valderrama BP, Suárez C, de-Velasco G, Beato C, Chirivella I, et al. SEOM clinical guideline for treatment of kidney cancer (2019). Clin Transl Oncol. 2020 Feb;22:256–269.; https://hdl.handle.net/11351/6315Test; 000514525700010

الإتاحة: https://doi.org/10.1007/s12094-019-02285-7Test
https://hdl.handle.net/11351/6315Test

المؤلفون: Bamias, A., Merseburger, A.S., Loriot, Y., James, N., Choy, E., Castellano, D., Lopez-Rios, F., Calabrò, F., Kramer, M., de Velasco, G., Zakopoulou, R., Tzannis, K., Sternberg, C.N.

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/141950/1/PIIS2059702921001125.pdfTest; Bamias, A., Merseburger, A.S., Loriot, Y., James, N., Choy, E. https://orca.cardiff.ac.uk/view/cardiffauthors/A227873K.htmlTest orcid:0000-0003-4459-8609 orcid:0000-0003-4459-8609, Castellano, D., Lopez-Rios, F., Calabrò, F., Kramer, M., de Velasco, G., Zakopoulou, R., Tzannis, K. and Sternberg, C.N. 2021. SAUL, a single-arm study of atezolizumab for chemotherapy-pretreated locally advanced or metastatic carcinoma of the urinary tract: outcomes by key baseline factors, PD-L1 expression and prior platinum therapy. ESMO Open 6 (3) , 100152. 10.1016/j.esmoop.2021.100152 https://doi.org/10.1016/j.esmoop.2021.100152Test file https://orca.cardiff.ac.uk/id/eprint/141950/1/PIIS2059702921001125.pdfTest

الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100152Test
https://orca.cardiff.ac.uk/id/eprint/141950Test/
https://orca.cardiff.ac.uk/id/eprint/141950/1/PIIS2059702921001125.pdfTest

المؤلفون: Wells, JC, Dudani, S, Gan, CL, Stukalin, I, Azad, AA, Liow, E, Donskov, F, Yuasa, T, Pal, SK, De Velasco, G, Hansen, AR, Beuselinck, B, Kollmannsberger, CK, Powles, T, McGregor, BA, Duh, MS, Huynh, L, Heng, DYC

العلاقة: pii: S1558-7673(21)00069-0; Wells, J. C., Dudani, S., Gan, C. L., Stukalin, I., Azad, A. A., Liow, E., Donskov, F., Yuasa, T., Pal, S. K., De Velasco, G., Hansen, A. R., Beuselinck, B., Kollmannsberger, C. K., Powles, T., McGregor, B. A., Duh, M. S., Huynh, L. & Heng, D. Y. C. (2021). Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. CLINICAL GENITOURINARY CANCER, 19 (4), pp.354-361. https://doi.org/10.1016/j.clgc.2021.03.006Test.; http://hdl.handle.net/11343/288773Test

الإتاحة: https://doi.org/10.1016/j.clgc.2021.03.006Test
http://hdl.handle.net/11343/288773Test

المؤلفون: Gan, CL, Dudani, S, Wells, JC, Donskov, F, Pal, SK, Dizman, N, Rathi, N, Beuselinck, B, Yan, F, Lalani, A-KA, Hansen, A, Szabados, B, de Velasco, G, Tran, B, Lee, JL, Vaishampayan, UN, Bjarnason, GA, Subasri, M, Choueiri, TK, Heng, DYC

العلاقة: Gan, C. L., Dudani, S., Wells, J. C., Donskov, F., Pal, S. K., Dizman, N., Rathi, N., Beuselinck, B., Yan, F., Lalani, A. -K. A., Hansen, A., Szabados, B., de Velasco, G., Tran, B., Lee, J. L., Vaishampayan, U. N., Bjarnason, G. A., Subasri, M., Choueiri, T. K. & Heng, D. Y. C. (2021). Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. CANCER MEDICINE, 10 (4), pp.1212-1221. https://doi.org/10.1002/cam4.3717Test.; http://hdl.handle.net/11343/272785Test

الإتاحة: https://doi.org/10.1002/cam4.3717Test
http://hdl.handle.net/11343/272785Test

المؤلفون: Martín-Soberón, M. C., Ruiz, S., De Velasco, G., Yarza, R., Carretero, A., Castellano, D., Sepúlveda-Sánchez, J. M.

المصدر: Journal of Medical Case Reports ; volume 15, issue 1 ; ISSN 1752-1947

مصطلحات موضوعية: General Medicine

الإتاحة: https://doi.org/10.1186/s13256-020-02581-9Test